CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 9,265 enrolled
Drug / intervention
Educational Outreach +3 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05132322
NCT05132322N/AActive

Eliminating Monitor Overuse (EMO) Hybrid Effectiveness-Deimplementation Trial

Children's Hospital of Philadelphia·interventional·Posted Nov 24, 2021·Updated Feb 13, 2026

In Brief

A clinical study evaluating Educational Outreach, Audit & Feedback (unit level), and 2 other interventions for Bronchiolitis Acute Viral. Active but no longer recruiting, targeting 9,265 participants across 51 sites in 2 countries.

Detailed Summary

The purpose of this study is to identify the optimal deimplementation strategies for an overused practice: continuous pulse oximetry monitoring of children hospitalized with bronchiolitis who are not receiving supplemental oxygen.

Study Details

Timeline

N/AActive
20222023202420252026
First PostedNov 24, 2021
Enrollment StartDec 1, 2021
Primary CompletionMar 31, 2024
Study CompletionAug 1, 2026
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 4.6 years ago

Interventions

Educational Outreachbehavioral

Educational outreach includes staff-targeted educational materials and outreach sessions summarizing the current evidence and guideline recommendations for pulse oximetry use in bronchiolitis.

Audit & Feedback (unit level)behavioral

Weekly unit-level feedback of each hospital's guideline-concordant practice will be distributed to sites in the form of a visual dashboard that includes comparisons over time and between hospitals. The dashboard will then be shared locally on a weekly basis with clinicians in person and electronically.

Audit & Feedback (real time, individual-level)behavioral

Real-time feedback will occur at the individual clinician level. When collecting data on an individual patient, data collectors encountering guideline-discordant continuous monitoring are empowered to briefly ask any available clinician responsible for that patient's care, in a nonjudgmental way, about indications for monitoring that patient. The clinician is ultimately responsible for deciding if any changes are indicated.

Clinical Pathway Integrated into Electronic Health Recordbehavioral

Clinical pathways guide clinicians step-by-step through evidence-based care. Based on the existing guidelines for physiologic monitoring in bronchiolitis, the pathway will clearly specify (a) situations when it is appropriate to initiate intermittent SpO2 measurement instead of continuous SpO2 monitoring, and (b) when it is appropriate to discontinue continuous SpO2 monitoring altogether, and transition to intermittent SpO2 measurement. In order to be visible to clinicians as they perform patient care, the pathway will be integrated into the electronic health record at sites randomized to this intervention.